Archive: 09/08/2018
New treatment for non-Hodgkin lymphoma approved
(HealthDay)—Poteligeo (mogamulizumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with two types of non-Hodgkin lymphoma.
Aug 9, 2018
(HealthDay)—Poteligeo (mogamulizumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with two types of non-Hodgkin lymphoma.
Aug 9, 2018